Monitoring stimulated cycles during in vitro fertilization treatment with ultrasound only preliminary results

Gynecological Endocrinology

Volumn 28, Issue 6, 2012, Pages 429-431

  Wiser, Amir ^a,b   Gonen, Ofer ^a,b   Ghetler, Yehudit ^a,b   Shavit, Tal ^a,b   Berkovitz, Arie ^a,b   Shulman, Adrian ^a,b  

^a MEIR MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

IVF; Ovulation induction; Pregnancy rate; Ultrasound monitoring

Indexed keywords

CHORIONIC GONADOTROPIN; ESTRADIOL; PROGESTERONE; RECOMBINANT CHORIONIC GONADOTROPIN; RECOMBINANT FOLLITROPIN; TRIPTORELIN;

ADULT; ARTICLE; BLOOD SAMPLING; CELL SIZE; CLINICAL ARTICLE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; ECHOGRAPHY; EMBRYO INDUCTION; ENDOMETRIUM; ESTRADIOL BLOOD LEVEL; FEMALE; FERTILIZATION IN VITRO; HEALTH CARE COST; HUMAN; OVARIAN RESERVE; OVARY FOLLICLE; OVARY HYPERSTIMULATION; PATIENT MONITORING; PATIENT SAFETY; PREGNANCY RATE; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; THICKNESS;

ADULT; BLOOD CHEMICAL ANALYSIS; EMBRYO TRANSFER; ENDOMETRIUM; FEMALE; FERTILIZATION IN VITRO; HUMANS; INFERTILITY, FEMALE; MENSTRUAL CYCLE; MONITORING, PHYSIOLOGIC; OVARIAN FOLLICLE; OVARIAN HYPERSTIMULATION SYNDROME; OVULATION INDUCTION; PILOT PROJECTS; PREGNANCY; PREGNANCY RATE; ULTRASONOGRAPHY, PRENATAL;

EID: 84861067148     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.3109/09513590.2011.633666     Document Type: Article

References (16)

1. Healy DL, Trounson AO, Andersen AN. Female infertility: causes and treatment. Lancet 1994;343:1539-1544. (Pubitemid 24180053)
2. Thomas K, Searle T, Quinn A, Wood S, Lewis-Jones I, Kingsland C. The value of routine estradiol monitoring in assisted conception cycles. Acta Obstet Gynecol Scand 2002;81:551-554. (Pubitemid 34628085)
3. Toner JP, Hassiakos DK, Muasher SJ, Hsiu JG, Jones HW Jr. Endometrial receptivities after leuprolide suppression and gonadotropin stimulation: histology, steroid receptor concentrations, and implantation rates. Ann N Y Acad Sci 1991;622:220-229.
4. Margalioth EJ, Taney FH, Cooper GW, Scholl GM, Rosenfeld DL. Correlations between serum oestradiol level on day of HCG and speed of embryonic development in in-vitro fertilization. Hum Reprod 1993;8:752-754. (Pubitemid 23164295)
5. Humaidan P, Quartarolo J, Papanikolaou EG. Preventing ovarian hyperstimulation syndrome: guidance for the clinician. Fertil Steril 2010;94:389-400.
6. Golan A, Herman A, Soffer Y, Bukovsky I, Ron-El R. Ultrasonic control without hormone determination for ovulation induction in in-vitro fertilization/embryo transfer with gonadotrophin-releasing hormone analogue and human menopausal gonadotrophin. Hum Reprod 1994;9:1631-1633. (Pubitemid 24291074)
7. Lass A; UK Timing of hCG Group. Monitoring of in vitro fertilizationembryo transfer cycles by ultrasound versus by ultrasound and hormonal levels: a prospective, multicenter, randomized study. Fertil Steril 2003;80:80-85. (Pubitemid 36808859)
8. Loumaye E, Engrand P, Howles CM, O'Dea L. Assessment of the role of serum luteinizing hormone and estradiol response to folliclestimulating hormone on in vitro fertilization treatment outcome. Fertil Steril 1997;67:889-899. (Pubitemid 27195030)
9. Kwan I, Bhattacharya S, McNeil A, van Rumste MM. Monitoring of stimulated cycles in assisted reproduction (IVF and ICSI). Cochrane Database Syst Rev 2008:CD005289.
10. Soldevila PN, Carreras O, Tur R, Coroleu B, Barri PN. Sonographic assessment of ovarian reserve. Its correlation with outcome of in vitro fertilization cycles. Gynecol Endocrinol 2007;23:206-212. (Pubitemid 46763726)
11. Nakamura S, Douchi T, Oki T, Ijuin H, Yamamoto S, Nagata Y. Relationship between sonographic endometrial thickness and progestin-induced withdrawal bleeding. Obstet Gynecol 1996;87: 722-725.
12. Shulman A, Shulman N, Weissenglass L, Bahary C. Ultrasonic assessment of the endometrium as a predictor of oestrogen status in amenorrhoeic patients. Hum Reprod 1989;4:616-619. (Pubitemid 19213193)
13. Navot D, Bergh PA, Laufer N. Ovarian hyperstimulation syndrome in novel reproductive technologies: prevention and treatment. Fertil Steril 1992;58:249-261.
14. Blankstein J, Shalev J, Saadon T, Kukia EE, Rabinovici J, Pariente C, Lunenfeld B, et al. Ovarian hyperstimulation syndrome: prediction by number and size of preovulatory ovarian follicles. Fertil Steril 1987;47:597-602. (Pubitemid 17065622)
15. Olivennes F, Howles CM, Borini A, Germond M, Trew G, Wikland M, Zegers-Hochschild F, et al.; CONSORT study group. Individualizing FSH dose for assisted reproduction using a novel algorithm: the CONSORT study. Reprod Biomed Online 2009;18:195-204.
16. Fauser BC, Van Heusden AM. Manipulation of human ovarian function: physiological concepts and clinical consequences. Endocr Rev 1997;18:71-106. (Pubitemid 27076456)